Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature
Open Access
- 13 June 2022
- journal article
- review article
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 48 (1) , 1-5
Abstract
Background: COVID toes or chilblain-like skin lesions have been widely reported during COVID-19 pandemic. Most cases were described in patients with negative microbiological tests for SARS-CoV-2, therefore the possible relationship with SARS-CoV-2 infection, as well as with the nowadays broadly available mRNA-based vaccination, has not been fully elucidated. Case presentation: We here describe the case of a 14-year-old male who developed chilblain-like skin eruptions during SARS-CoV-2 infection despite two mRNA-based vaccine doses and review the clinical and epidemiological characteristics of chilblain-like lesions as a cutaneous presentation of COVID-19 in children. Conclusions: Most children and adolescent with COVID toes have a mild or asymptomatic SARS-CoV-2 infection. Our report aims to highlight the possible onset of these skin lesions in vaccinated children, if infection has occurred, and the potential use of systemic corticosteroids as a first line treatment. Additional evidence is required to better understand SARS-CoV-2 infection and cutaneous manifestations in children and determine the relationship between chilblain-like lesions and COVID-19 vaccination.Keywords
All Related Versions
This publication has 22 references indexed in Scilit:
- Lessons From the First Wave of the Pandemic: Skin Features of COVID-19 Can Be Divided Into Inflammatory and Vascular PatternsJournal of Cutaneous Medicine and Surgery, 2020
- Treatment of COVID‐19 induced chilblains with topical nitroglycerinInternational Journal of Dermatology, 2020
- Evaluation of Chilblains as a Manifestation of the COVID-19 PandemicJAMA Dermatology, 2020
- Assessment of Acute Acral Lesions in a Case Series of Children and Adolescents During the COVID-19 PandemicJAMA Dermatology, 2020
- Chilblain-like acral lesions during the COVID-19 pandemic (“COVID toes”): Histologic, immunofluorescence, and immunohistochemical study of 17 casesJournal of the American Academy of Dermatology, 2020
- Most chilblains observed during the COVID‐19 outbreak occur in patients who are negative for COVID‐19 on polymerase chain reaction and serology testing*British Journal of Dermatology, 2020
- A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain‐like lesions: lights and shadows on the relationship with COVID‐19 infectionJournal of the European Academy of Dermatology and Venereology, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- The treatment of chilblains with nifedipine: the results of a pilot study, a double-blind placebo-controlled randomized study and a long-term open trialBritish Journal of Dermatology, 2006
- Corticosteroid therapy for pernioJournal of the American Academy of Dermatology, 1983